STOCK TITAN

ParkerVision (OTCQB: PRKR) Q1 2026 loss narrows amid key CAFC appeal

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ParkerVision, Inc. reported results for the three months ended March 31, 2026. Licensing revenue was $0 and net loss was $1.553 million, compared with a net loss of $3.799 million a year earlier, or $0.01 per share versus $0.03 per share.

Cash and cash equivalents were $3.423 million as of March 31, 2026, down from $4.360 million at year-end 2025. The balance sheet shows contingent payment obligations of $46.486 million and shareholders’ deficit of $45.524 million.

The company highlighted legal developments, including the Court of Appeals for the Federal Circuit granting an expedited schedule in its appeal in ParkerVision v. Qualcomm, with oral arguments set for June 1, 2026, and noted ongoing patent cases in Texas.

Positive

  • None.

Negative

  • None.

Insights

ParkerVision posts narrower loss, limited cash, and key near-term appeal date.

ParkerVision reported no licensing revenue for Q1 2026 and a net loss of $1.553M, improved from $3.799M a year earlier. Operating expenses fell, and the change in fair value of contingent payment obligations was a smaller charge than in the prior-year quarter.

Cash stood at $3.423M on March 31, 2026, down from $4.360M on December 31, 2025, while contingent payment obligations remained large at $46.486M. The company continues to report a shareholders’ deficit, indicating liabilities exceed assets.

On the legal front, the Court of Appeals for the Federal Circuit granted an expedited schedule in the Qualcomm appeal, with oral arguments on June 1, 2026. Outcomes of this appeal and pending Texas cases, as described, may influence future financial results, but the filing does not quantify potential impacts.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net loss Q1 2026 $1.553M Three months ended March 31, 2026
Net loss Q1 2025 $3.799M Three months ended March 31, 2025
Basic and diluted net loss per share $0.01 Three months ended March 31, 2026
Cash and cash equivalents $3.423M As of March 31, 2026
Contingent payment obligations $46.486M As of March 31, 2026
Shareholders’ deficit $45.524M As of March 31, 2026
Selling, general and administrative expenses $0.958M Three months ended March 31, 2026
Weighted average shares outstanding 144,778 Three months ended March 31, 2026 (in thousands of shares)
contingent payment obligations financial
"Contingent payment obligations | | | 46,486 | | | | 46,089 |"
shareholders’ deficit financial
"Shareholders’ deficit | | | (45,524 | ) | | | (45,104 | )"
Court of Appeals for the Federal Circuit regulatory
"The Court of Appeals for the Federal Circuit ("CAFC") granted the Company's motion"
forward-looking statements regulatory
"This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
change in fair value financial
"Change in fair value of contingent payment obligations | | | (397 | ) | | | (2,461 | )"
net cash used in operating activities financial
"Net cash used in operating activities | | $ | (851 | ) | | $ | (1,827 | )"
Net cash used in operating activities is the amount of cash a company’s core business operations consumed during a period—essentially cash paid out for everyday activities (like payroll, suppliers and rent) minus cash received from customers. Investors watch it as a measure of whether the business’s day-to-day operations are self-sustaining or draining cash, much like checking whether a household’s regular income covers its monthly bills rather than relying on savings or borrowing.
Licensing revenue $0
Net loss $1.553M
Net loss per share $0.01 basic and diluted
Cash and cash equivalents $3.423M
false 0000914139 0000914139 2026-05-07 2026-05-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): May 7, 2026
 
PARKERVISION, INC.
(Exact Name of Registrant as Specified in Charter)
     
Florida
000-22904
59-2971472
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
   
4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida
32207
(Address of Principal Executive Offices)
(Zip Code)
 
(904) 732-6100
(Registrant’s Telephone Number, Including Area Code)
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
Trading Symbol
Name of Each Exchange on Which Registered
None
 
 
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.
 
Emerging growth company   
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
 
 

 
 
Item 2.02 Results of Operations and Financial Condition
 
On May 7, 2026,  ParkerVision, Inc. (the “Company”) issued a press release which reported financial and operating results for the three months ended March 31, 2026.  A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
 
The information contained in this Current Report on Form 8-K, including Exhibit 99.1 hereto, has been “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section.  The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits:
 
Exhibit Description
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
Dated: May 7, 2026
   
   
PARKERVISION, INC.
     
   
By /s/ Cynthia French
   
Cynthia French
   
Chief Financial Officer
 
 

 Exhibit 99.1

 

 

ParkerVision Reports First Quarter 2026 Results

 

JACKSONVILLE, Fla., May 7, 2026  ParkerVision, Inc. (OTCQB: PRKR) (“ParkerVision” or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three months ended March 31, 2026.

 

 2026 Summary and Recent Developments

 

 

The Court of Appeals for the Federal Circuit ("CAFC") granted the Company's motion for an expedited schedule in its appeal of ParkerVision v. Qualcomm (CAFC case no. 26-1033) and oral arguments are scheduled for

June 1, 2026.  

     
      The Company appealed the May 30, 2025 claim construction ruling made by the district court (Middle District of Florida) which led to a stipulation of noninfringement of the Company's receiver patent claims. The district court severed and stayed the remaining transmitter patent claims in the case pending the decision of the appellate court.  
       
      The briefings to the CAFC and the oral arguments on June 1, 2026 will address the merits of the appeal and a request for the case to be assigned to a new judge, as well as address whether the CAFC has proper jurisdiction based on a motion to dismiss the appeal filed by Qualcomm.

 

  The Company's first patent infringement trial against MediaTek in the Western District of Texas was postponed by the district court, just days prior to the scheduled trial, pending resubmission of expert reports and related briefings by the parties.  
     
      A revised scheduling order has been issued for MediaTek providing for submission of revised expert reports by the Company by May 8, 2026, submission of MediaTek's responsive expert reports in June 2026, and final deadlines for pretrial motions by the end of July 2026.  A trial commencement date has not yet been established.
         
  The Company's patent infringement trial against Realtek in the Western District of Texas, originally scheduled to commence in late April 2026, was postponed by the district court citing the same reasons as the MediaTek case.  
         
      In April 2026, it was reported that Judge Albright, the district court judge assigned to each of ParkerVision's Texas cases, will be leaving the bench, and on April 24, 2026, Albright issued an order vacating all pending dates for a number of cases, including ParkerVision v. Realtek.
         

Jeffrey Parker, CEO of ParkerVision, commented, “We are very appreciative that the CAFC has continued to move expeditiously with respect to our Qualcomm appeal, and we are eager to argue the merits of our appeal to the panel on June 1st.  This case has now surpassed the twelve-year anniversary of our initial filing in district court, and I believe at this point, we have proven our determination to have this case heard by a jury and our willingness to persevere."  

 

Mr. Parker continued, "We had hoped to be reporting on the jury results of two Texas cases by this time.  While we are disappointed in the shift in the timeline, we do believe the court, by giving us an opportunity to modify our expert reports, has given us guidance in ensuring those reports are less vulnerable to challenges by others.  We are eagerly awaiting insight into the judicial changes in the Western District of Texas and how that might impact our pending cases in Waco, Texas."

 

 

 

Financial Results

 

 

ParkerVision reported a net loss for the three months ended March 31, 2026 of $1.6 million, or $0.01 per common share, compared to a net loss of $3.8 million, or $0.03 per common share for the three months ended March 31, 2025.

 

 

The decrease in net loss is primarily the result of a $2.1 million decrease in loss resulting from increases in the estimated fair value of the Company's contingent payment obligations. The changes in fair value, and resulting losses recognized, result from changes in estimated probabilities, amounts and timing of projected future repayments of the Company's contingent payment obligations.  The assumptions used in these estimates are highly subjective and may not be reflective of amounts repaid in the future which are contingent upon receipt of proceeds from patent enforcement, licensing and other patent-related items.  

 

 

The Company used approximately $0.9 million in cash for operations for the first three months of 2026 and ended the quarter with $3.4 million in cash and cash equivalents.

 

 

 

 

About ParkerVision

 

ParkerVision, Inc. invents, develops and licenses cutting-edge, proprietary radio-frequency (RF) technologies that enable wireless solution providers to make and sell advanced wireless communication products. ParkerVision is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are broadly infringed by others. For more information, please visit www.parkervision.com. (PRKR-I)

 

Safe Harbor Statement

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These include statements regarding the timing, scheduling, and expected outcomes of current and future legal proceedings; the potential impact and significance of such proceedings; and expectations concerning court and PTAB rulings, trial dates, and pre-trial motions.  Forward-looking statements also include estimates and assumptions underlying financial information, including the fair value of contingent payment obligations and the Companys ability to support ongoing operations and litigation.

 

These statements are based on current expectations, estimates, projections, and assumptions as of the date of this release, and involve known and unknown risks and uncertainties that could cause actual results to differ materially.  Words such as believe, optimistic,” “expect,” “will," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements include these words. Risks and uncertainties that may cause actual results to differ include, among others: adverse developments or delays in legal proceedings; unfavorable court or PTAB decisions or rulings; the loss or unavailability of key expert witnesses; the availability of funding for continued operations and litigation; changes in the legal or regulatory environment; inaccuracies in financial estimates or assumptions; and risks disclosed in the Companys filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent filings.

 

Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made.  Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.

 

 

 



Cindy French

Chief Financial Officer

ParkerVision, Inc

cfrench@parkervision.com





 

(TABLES FOLLOW)

 

 

 

ParkerVision, Inc.

Balance Sheet Highlights (unaudited)



   

(unaudited)

         

(in thousands)

 

March 31, 2026

   

December 31, 2025

 

Cash and cash equivalents

  $ 3,423     $ 4,360  

Prepaid expenses and other current assets

    419       304  

Intangible assets & other noncurrent assets

    659       695  

Total assets

    4,501       5,359  
                 

Current liabilities

    2,112       2,409  

Contingent payment obligations

    46,486       46,089  

Convertible notes, net of current portion

    1,408       1,908  

Other long-term liabilities

    19       57  

Shareholders’ deficit

    (45,524 )     (45,104 )

Total liabilities and shareholders’ deficit

  $ 4,501     $ 5,359  

 

ParkerVision, Inc.

Summary Results of Operations (unaudited)

 

   

Three Months Ended

 

(in thousands, except per share amounts)

 

March 31,

 
   

2026

   

2025

 

Licensing revenue

  $ -     $ -  

Cost of sales

    (36 )     (54 )

Gross margin

    (36 )     (54 )
                 

Selling, general and administrative expenses

    958       1,243  

Total operating expenses

    958       1,243  
                 

Interest expense and other

    (162 )     (41 )

Change in fair value of contingent payment obligations

    (397 )     (2,461 )

Total other income (expense)

    (559 )     (2,502 )
                 

Net loss

  $ (1,553 )   $ (3,799 )
                 

Basic and diluted net loss per common share

  $ (0.01 )   $ (0.03 )
                 

Weighted average shares outstanding

    144,778       115,831  

 

 

 

ParkerVision, Inc.

Summary of Cash Flows

(unaudited)

 

   

Three Months Ended

 

(in thousands)

 

March 31,

 
   

2026

   

2025

 

Net cash used in operating activities

  $ (851 )   $ (1,827 )

Net cash used in investing activities

    -       (34 )

Net cash (used in) provided by financing activities

    (86 )     223  
                 

Net decrease in cash and cash equivalents

    (937 )     (1,638 )
                 

Cash and cash equivalents - beginning of period

    4,360       4,918  
                 

Cash and cash equivalents - end of period

  $ 3,423     $ 3,280  



 

FAQ

How did ParkerVision (PRKR) perform financially in Q1 2026?

ParkerVision reported no licensing revenue and a net loss of $1.553 million for Q1 2026. This compares to a net loss of $3.799 million in the prior-year quarter, with basic and diluted net loss per share improving from $0.03 to $0.01.

What was ParkerVision (PRKR)'s cash position as of March 31, 2026?

ParkerVision had cash and cash equivalents of $3.423 million as of March 31, 2026. This was down from $4.360 million at December 31, 2025, reflecting net cash used in operating and financing activities during the first quarter of 2026.

What are ParkerVision (PRKR)'s key balance sheet obligations in Q1 2026?

As of March 31, 2026, ParkerVision reported contingent payment obligations of $46.486 million and convertible notes, net of current portion, of $1.408 million. The company also showed a shareholders’ deficit of $45.524 million, indicating liabilities exceed total assets.

How did ParkerVision (PRKR)'s operating expenses change in Q1 2026?

Selling, general and administrative expenses were $958,000 in Q1 2026, compared with $1.243 million in Q1 2025. Total operating expenses matched this $958,000 figure, reflecting reduced spending versus the prior-year period alongside continued net losses.

What did ParkerVision (PRKR)'s cash flow statement show for Q1 2026?

Net cash used in operating activities was $851,000 in Q1 2026, compared with $1.827 million in Q1 2025. Net cash used in financing activities totaled $86,000, leading to a $937,000 decrease in cash and cash equivalents during the quarter.

Filing Exhibits & Attachments

5 documents